LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 61.56 | 27.76 | 1061 | 6217 | 0.1707 | 0.5947 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 61.56 | 27.76 | 1092 | 6217 | 0.1756 | 0.6006 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.26 | 27.76 | 992 | 6465 | 0.1534 | 0.5758 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.26 | 27.76 | 1008 | 6465 | 0.1559 | 0.5790 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.26 | 27.76 | 1107 | 6465 | 0.1712 | 0.5979 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.26 | 27.76 | 1124 | 6465 | 0.1738 | 0.6010 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.97 | 27.76 | 990 | 6656 | 0.1487 | 0.5716 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.97 | 27.76 | 1003 | 6656 | 0.1507 | 0.5742 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.97 | 27.76 | 1105 | 6656 | 0.1660 | 0.5936 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.97 | 27.76 | 1121 | 6656 | 0.1684 | 0.5965 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 66.67 | 27.76 | 996 | 6695 | 0.1488 | 0.5721 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 66.67 | 27.76 | 1009 | 6695 | 0.1507 | 0.5746 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 66.67 | 27.76 | 1099 | 6695 | 0.1641 | 0.5917 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 66.67 | 27.76 | 1114 | 6695 | 0.1664 | 0.5945 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 68.37 | 27.76 | 997 | 6879 | 0.1449 | 0.5688 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 68.37 | 27.76 | 1012 | 6879 | 0.1471 | 0.5717 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 68.37 | 27.76 | 1137 | 6879 | 0.1653 | 0.5949 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 68.37 | 27.76 | 1151 | 6879 | 0.1673 | 0.5974 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.08 | 27.76 | 1015 | 6849 | 0.1482 | 0.5729 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.08 | 27.76 | 1027 | 6849 | 0.1499 | 0.5752 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.08 | 27.76 | 1111 | 6849 | 0.1622 | 0.5908 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.08 | 27.76 | 1128 | 6849 | 0.1647 | 0.5939 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 71.78 | 27.76 | 1015 | 6893 | 0.1473 | 0.5720 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 71.78 | 27.76 | 1029 | 6893 | 0.1493 | 0.5747 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 71.78 | 27.76 | 1160 | 6893 | 0.1683 | 0.5986 | MN20160318_Q01 | H10 |